Life Extension Peptide Research

Longevity research has identified several hallmarks of aging — genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, and altered intercellular communication. Research peptides targeting these pathways are central to modern biogerontology.

Laboratory studies using these compounds investigate the fundamental mechanisms of cellular aging, offering insights into how specific peptide interventions modify aging biomarkers in cell culture and tissue models.

• Epithalon (Epitalon): A tetrapeptide (Ala-Glu-Asp-Gly) studied for its effects on telomerase activity in human fibroblast cultures. Research by Khavinson et al. demonstrated telomere elongation in somatic cell models
• NAD+ (Nicotinamide Adenine Dinucleotide): A critical coenzyme studied for its role in sirtuin activation, DNA repair (via PARP), and mitochondrial function in aging cell models
• FOXO4-DRI: A peptide designed to disrupt FOXO4/p53 interaction in senescent cells. Research demonstrates selective apoptosis induction in senescent cell populations while sparing healthy cells
• SS-31 (Elamipretide): A mitochondria-targeted peptide that binds cardiolipin on the inner mitochondrial membrane, studied for its effects on electron transport chain efficiency and ROS production
• MOTS-c: A mitochondrial-derived peptide that activates AMPK signaling, studied for its effects on metabolic homeostasis and exercise-mimetic pathways
• GHK-Cu: A copper-tripeptide complex studied for its effects on gene expression patterns, with research showing modulation of over 4,000 genes related to tissue remodeling

Modern longevity research focuses on several interconnected biological pathways:

• Telomere biology: Telomerase activation, shelterin complex integrity, and replicative senescence in cell culture models
• Mitochondrial function: Electron transport chain efficiency, ROS management, and mitochondrial biogenesis signaling (PGC-1a pathway)
• Senescence and senolytics: Identification and selective clearance of senescent cells using targeted peptides like FOXO4-DRI
• NAD+ metabolism: Sirtuin activation, PARP-mediated DNA repair, and CD38/NADase regulation in aging models
• Growth hormone axis: GH secretagogues (tesamorelin, sermorelin, ipamorelin) and their effects on IGF-1 signaling in aging tissue models

Researchers studying aging biology typically employ multiple complementary compounds to investigate interconnected pathways. Key considerations include:

• Biomarker selection: Telomere length (qPCR), SA-beta-galactosidase staining (senescence), mitochondrial membrane potential (JC-1 assay), and NAD+/NADH ratio
• Cell model selection: Human fibroblasts (WI-38, IMR-90) for replicative aging, iPSC-derived cells for disease models, and primary cultures for tissue-specific studies
• Compound interactions: Many longevity peptides target parallel pathways — understanding potential synergies and antagonisms is critical for multi-compound protocols